In what’s believed to be the largest such effort to date, a clinical trial expected to launch this week will examine the effectiveness of a possible blood test to detect autism.
The 20-site trial is slated to include 660 patients in an attempt to identify children with autism as opposed to other developmental delays through a blood test.
The effort is part of a broader movement to find ways to diagnose kids at younger ages. Experts say earlier diagnosis is important because children with autism respond best to therapy when it begins early.
The new study being sponsored by the company SynapDx is based on findings from several research groups including the work of a team at Boston Children’s Hospital who found that they could accurately differentiate between kids with autism and children with other developmental delays in about two-thirds of cases.
Those behind the initial research say it’s a good starting point, but much more work remains before a diagnosis will be able to be made on biomarkers alone, reports The Wall Street Journal. To read more click here.